FDA Investigator Barbara A Gullick
Barbara A Gullick has conducted inspections on 135 sites in 1 countries as of 27 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
135
Last Inspection Date:
27 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Barbara A Gullick:
Alice S Tsao,
Alison N Stieg,
Allison E Sincek,
Amanda B Athey,
Amy C Amaro,
Anastasia M Shields,
Andrea L Williams Jones,
Ann Marie Karnick,
Anne E Johnson,
Anthony W Lee,
Ashley M Whitehurst,
Austin B Appler,
Barbara A Burke,
Barbara J Holladay,
Bijoy Panicker,
Brandon L Mariner,
Brooke K Higgins,
Bruce E Kummer,
Camilla S Smith,
Chaltu Nwakijra,
Charles D Boison,
Charles M Kerns, BLT DO,
Cherlita A Honeycutt,
Chiang Syin, PhD,
Christina K Theodorou,
Christine W Twohy,
Christopher D Leach,
Craig D Zagata,
Cynthia A Harris, MD, RN,
Daniel W Johnson,
David A Oluwo,
David P Rice, Jr,
Dennis R Hock,
Djamila Harouaka,
Douglas A Campbell,
Dr. Dominick Roselle,
Dr. Roslyn F Powers,
Dr. Yubing Tang,
Edette J Newby,
Edmund F Mrak, Jr,
Edward P Potter,
Edwin L Hobbs,
Elizabeth A Laudig,
Elvis D Morton,
Emest F Bizjak,
Emily A Walters,
Emmanuel A Dimaano, Jr,
Erika M Wilkerson,
Gail L Katz,
Gayle S Lawson,
George Pyramides,
Gerald Mierle,
Heath R Harley,
Hector Jcolon Torres,
Helen B Ricalde,
Holly S Simms,
Jaclyn N Munsch,
James M Mason,
James M Simpson,
James T Mccoy,
James W Leonette,
Jamie D Swann,
Jeanne D Shaffer,
Jeanne F Broderick,
Jeffrey A Reed,
Jeffrey A Sincek,
Jennifer A Jones,
Jessica D Nanini,
Joanne S Wilson,
Johnson,
Jonah S Ufferfilge,
Jonathan W Chapman,
Joseph W Matthews,
Julianne C Mccullough,
Julie A Silberberg,
Junho Pak,
Justin C Fuller,
Justin H Price,
Karen A Spencer,
Kathleen M Jordan,
Kenneth L Smalls,
Kenneth M Gordon,
Kenneth Nieves,
Kimberly A Dux,
Kip J Hanks,
Kish Bolden,
Ko U Min,
Krista N Flores,
Kristina L Conroy,
La Tasham Gunter,
Lakisha M Williams,
Laurie A Haxel,
Laurissa S Flowers,
Lawrence Harmon, Jr,
Lawrence J Stringer,
LCDR Anastasia M Piliafas Brown,
LCDR Cornelius Brown, III,
LCDR Wilfred A Darang,
Linda M Hoover,
Linda S Mattingly,
Lori A Holmquist,
Lori S Lawless,
Lorraine L Chavis,
Louis G An,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Lucas B Leake,
Lynette P Salisbury,
Marcellinus D Dordunoo,
Marcus A Ray,
Margaret M Doherty,
Margaret Torres Vazquez,
Maricelys Mercado,
Marion W Nadeau,
Mary P Murphy,
Mary T Carden,
Matthew M Henciak,
Megan F Mclaughlin,
Megan M Lauff,
Melissa J Garcia,
Merideth K Rose,
Michael A Charles,
Michael Shanks, MS,
Michele M Falchek,
Michelle E Noonan Smith,
Mildred L Mccray,
Mohamad A Chahine,
Monique Rac Lester,
Myra L Gemmill,
Nancy L Meade,
Nancy L Rose,
Nebil A Oumer,
Nicholas A Violand,
Nicholas P Schaub,
Nikisha M Bolden,
Nina D Patel,
Normica G Facey,
Osama M Hamoud,
Patricia A Morrow,
Paula J Bretz,
Peter R Lenahan,
Philip W Beck,
Rachael O Oyewole,
Rachel C Harrington,
Regina Gibson Melton,
Richard J Bashay,
Robert E Davis,
Robert J Martin,
Rterry Bolen,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Simone E Pitts,
Stacey A Priest,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Stephany J Wesley,
Stephen R King,
Susan M Miller,
Suzanne M Healy,
Tamika E Allen, RN,
Tania E Vizcaino,
Teresa L Fox,
Tonia F Bernard,
Toniette K Williams,
Toyin B Oladimeji,
Valeria A Moore,
Valerie G Vallely,
Viviana Matta,
Vivin George,
Walter L Fava,
Wanda Y Fields,
Wanda Y Honeyblue,
William D Bassett, Jr,
Willy A Orantes,
Yvins Dezan,
Zachary L Miller,
Zhongren Wu
Barbara A Gullick's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2008 | FDA 483 | American Natl. Red Cross-Greater Chesapeake & Potomac Region - Form 483, 2008-06-23 |
June, 2001 | FDA 483 | Sitek Research Laboratories - Form 483, 2001-06-07 |
May, 2005 | FDA 483 | BRT Laboratories, Inc. - Form 483, 2005-05-24 |
April, 2003 | EIR | Culligan Water Company of Maryland, Inc. - EIR, 2003-04-02 |
November, 2002 | FDA 483 | Pharmaceutics International, Inc. - Form 483, 2002-11-14 |
June, 2001 | EIR | Sitek Research Laboratories - EIR, 2001-06-07 |
November, 2002 | FDA 483 Response | Pharmaceutics International, Inc. - Form 483R, 2002-11-14 |
November, 2002 | EIR | Pharmaceutics International, Inc. - EIR, 2002-11-14 |
May, 2003 | EIR | Baltimore Washington Medical Center - EIR, 2003-05-29 |
July, 2008 | FDA 483 | American Red Cross Biomedical Services Headquarters - Form 483, 2008-07-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more